The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., said the guidance generally excludes from regulation software that allows a health care provider or patient to independently review the basis for its treatment recommendations. In addition, FDA released draft guidance clarifying that certain digital health technologies, such as mobile apps intended solely to maintain or encourage a healthy lifestyle, generally fall outside the scope of FDA regulation under the Act, and final guidance adopting international principles for harmonizing the regulation of software with a medical purpose.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services late Friday issued a proposed rule updating payment rates for skilled nursing facilities for fiscal year 2020.
Headline
The Department of HHS’ Office of the National Coordinator for Health Information Technology and CMS today extended the deadline to comment on their proposed…
Headline
The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology today released an updated Trusted Exchange…
Headline
More than 9 in 10 hospitals used their electronic health record data to inform clinical practice in 2017.
Headline
The Centers for Medicare & Medicaid Services Friday finalized changes to the Medicare Advantage and prescription drug programs for contract year 2020.
Headline
WEDI, a public-private coalition of health information technology stakeholders including the AHA, will host its 2019 Spring Conference May 20-22 in San Diego.